GT Biopharma, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
GT Biopharma, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • GT Biopharma, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $30.000.
  • GT Biopharma, Inc. annual Operating Lease, Payments for 2023 was $118K, a 8.26% increase from 2022.
  • GT Biopharma, Inc. annual Operating Lease, Payments for 2022 was $109K.
  • GT Biopharma, Inc. annual Operating Lease, Payments for 2020 was $0.000, a 100% decline from 2019.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $118K +$9K +8.26% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $109K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2020 $0 -$120K -100% Jan 1, 2020 Dec 31, 2020 10-K 2021-04-16
2019 $120K Jan 1, 2019 Dec 31, 2019 10-K 2021-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.